Abstract: DNA-protein cross-links (DPCs) are unusually bulky DNA adducts that form in cells as a result of exposure to endogenous and exogenous agents including reactive oxygen species, ultraviolet light, ionizing radiation, environmental agents (e.g. transition metals, formaldehyde, 1,2-dibromoethane, 1,3-butadiene) and common chemotherapeutic agents. Covalent DPCs are cytotoxic and mutagenic due to their ability to interfere with faithful DNA replication and to prevent accurate gene expression. Key to our understanding of the biological significance of DPC formation is identifying the proteins most susceptible to forming these unusually bulky and complex lesions and quantifying the extent of DNA-protein cross-linking in cells and tissues. Recent advances in bottom-up mass spectrometry-based proteomics have allowed for an unbiased assessment of the whole protein DPC adductome after in vitro and in vivo exposures to cross-linking agents. This MiniReview summarizes current and emerging methods for DPC isolation and analysis by mass spectrometry-based proteomics. We also highlight several examples of successful applications of these novel methodologies to studies of DPC lesions induced by bis-electrophiles such as formaldehyde, 1,2,3,4-diepoxybutane, nitrogen mustards and cisplatin. [11] [12] [13] . DPCs can also form endogenously as a result of trapping DNA-interacting enzymes such as topoisomerases, polymerases, and base excision repair proteins on DNA intermediates, as well as a result of exposure to reactive oxygen species [14] [15] [16] , and aldehyde by-products of lipid peroxidation such as methylglyoxal [17] and malondialdehyde [18] . Age-related increases in DPC levels have been observed in the brain and heart tissues of laboratory mice [19, 20] . DPC formation has been proposed to play a role in ageing [19, 20] , cancer [21, 22] , heart disease [19, 20] and neurodegenerative disorders [23] .
DNA-protein cross-links (DPCs) are bulky DNA adducts formed when proteins become covalently trapped on chromosomal DNA [1] . DPCs can be induced by a variety of physical and chemical agents including transition metals [2] [3] [4] , halogenated hydrocarbons [5, 6] , ionizing radiation [7] , UV light [8] [9] [10] and reactive metabolites of anticancer drugs such as platinum drugs and nitrogen mustards (Scheme 1) [11] [12] [13] . DPCs can also form endogenously as a result of trapping DNA-interacting enzymes such as topoisomerases, polymerases, and base excision repair proteins on DNA intermediates, as well as a result of exposure to reactive oxygen species [14] [15] [16] , and aldehyde by-products of lipid peroxidation such as methylglyoxal [17] and malondialdehyde [18] . Age-related increases in DPC levels have been observed in the brain and heart tissues of laboratory mice [19, 20] . DPC formation has been proposed to play a role in ageing [19, 20] , cancer [21, 22] , heart disease [19, 20] and neurodegenerative disorders [23] .
Recent developments in biological mass spectrometry have allowed for great advances in mass spectrometry-based proteomics (MS proteomics). The new Orbitrap and Q-TOF mass spectrometers provide an improved data acquisition speed, high resolution and excellent mass accuracy (<10 ppm) of peptide fragments, allowing for sensitive and accurate protein identification. These improvements now allow for over 5,000 proteins to be identified in a single proteomics experiment, a number far exceeding the number of proteins expected to become crosslinked to DNA. This manuscript presents an overview of current methodologies for DPC isolation and analysis using mass spectrometry-based proteomics. A main emphasis will be placed on DPCs induced by bis-electrophiles. Additional information about the synthesis of site-specific hydrolytically stable DPCs [1] and the repair of DPCs can be found elsewhere [24, 25] .
Biological Effects of DPCs
The contribution of DPCs to cytotoxicity and mutagenicity of bis-electrophiles was first demonstrated by Liu et al. [5] . This group employed E. Coli bacteria overexpressing O 6 -alkylguanine-DNA alkyltransferase (AGT). AGT is a DNA repair protein that protects the human genome from the damaging effects of promutagenic O 6 -alkylguanine lesions [26] . After protein binding to damaged DNA, the O 6 -alkylguanine nucleotide is flipped out of the base stack into the AGT's active site, allowing for the O 6 -alkyl group to be transferred to an activated side-chain thiolate anion of Cys145 [27] . AGT typically protects cells from toxicity associated with exposure to alkylating agents. However, when E. Coli overexpressing AGT were exposed to the bifunctional electrophiles 1,2-bromoethane (DBE) and 1,2,3,4-diepoxybutane (DEB), toxic AGT-DNA cross-links were formed, leading to increased toxicity and mutations in cells overexpressing AGT [5] . These results suggested that DPC formation in living cells may lead to toxicity and mutations. One important limitation of these early studies was the challenge of establishing a cause-effect relationship between DPC formation and the observed biological effects. Cross-linking agents such as DBE and DEB form a range of toxic and mutagenic DNA adducts, for example DNA-DNA cross-links and monoadducts, in addition to DPCs. Our group has developed a novel methodology to selectively induce DPCs in living cells without the concomitant production of other toxic adducts [28] . In our approach, recombinant human C145A AGT protein was treated with DEB to induce a DNA-reactive 2-hydroxy-3,4-epoxybutyl moiety on cysteine 150, and the resulting protein containing a DNA-reactive epoxide group was purified by size exclusion. Electroporation of AGT monoepoxides into mammalian cell lines induced cell death and increased the frequency of mutations at the hprt gene (1.8 per 10
6 versus 1 per 10 6 , p < 0.01, chi-square). When C145A protein was replaced with a variant unable to accumulate in the nucleus (K125L), reduced toxicity and mutations were observed. Importantly, both toxicity and mutations correlated with the numbers of covalent DPCs as detected by HPLC-ESI-MS/MS [28] . These results provided the first direct evidence that DPC formation contributes to cell death and mutations induced by bis-electrophiles.
Due to their super-bulky nature, DPCs are expected to inhibit crucial biological processes of DNA replication and transcription, interfering with the faithful copying and expression of genetic information. The size of the protein constituent of the DPCs and the cross-linking site on DNA largely determine whether they completely block DNA replication/transcription or can be bypassed by DNA and RNA polymerases. Nakano et al. reported that DPCs over 14.1 kDa in size located on the translocating strand completely block DNA unwinding by human helicases (mini chromosome maintenance Mcm467 subcomplex), while DPCs between 5 and 14.1 kDa in size severely block helicase progression [29] . Our laboratory investigated the effects of DPCs and smaller DNA-peptide conjugates on DNA replication in vitro by human DNA polymerases [30, 31] . Hydrolytically stable model DPCs were site-specifically incorporated into DNA using reductive amination reactions between lysine side chains within a protein and 7-deaza-7-(2,3-dihydroxypropan-1-yl)-2 0 -deoxyguanosine in DNA [32] or via copper-catalysed [2 + 3] cycloaddition between azidefunctionalized proteins and 5-(octa-1,7-diynyl)-uracil in DNA [33] . We found that full-size DPC lesions completely blocked human DNA polymerases g, j, b and ι in primer extension experiments [30, 31] . However, TLS polymerases g and j were able to bypass the adducts when the protein was replaced with a 10-mer peptide [30, 33] . Polymerase bypass of 10-mer peptides attached to the C5 position of thymidine in DNA by hPol Scheme 1. Chemical structures of DNA-protein cross-links induced by methylglyoxal (1), malondialdehyde (2), 4-hydroxynonenal (3), formaldehyde (4), acrolein (5), 1,2,3,4-diepoxybutane (6), nitrogen mustards (7), cisplatin (8) and chromium III, where L stands for ligands such as water, ascorbate, glutathione, and other amino acids such as cysteine (9) .
ƞ and hPol j was highly error-prone, resulting in both base substitutions and deletions [30] . In contrast, the same lesions conjugated to the N7 position of DNA were not mispairing [31] . More recently, we investigated the effects of DPC lesions on transcription (Ji et al., unpublished data). We found that bacterial RNA polymerases were blocked by protein lesions conjugated to the N7 position of guanine, while smaller peptide lesions were bypassed. Lesions placed in the non-transcribed strand of DNA had a smaller effect on transcription (Ji et al., unpublished data). Taken together, these studies show the importance of the protein lesion size and conjugation site on DNA in defining their biological consequences.
DPC Isolation and Detection in Cells
The first reports of DNA-protein cross-linking in cells utilized biophysical approaches such as alkaline elution methodology [34] . In this method, DNA is radiolabelled with [
3 H]-thymidine in cell culture. Treated and control cells are lysed on a polyvinyl filter and washed with a lysis solution to remove intact proteins and lipids [34] . Free DNA is then eluted from the filter by washing with a basic solution, leaving the covalent DPCs trapped on the filter [34] [35] [36] . Treatment with proteinase K digests the protein constituent of DPCs, allowing for the cross-linked DNA to be eluted [35, 36] . Relative quantitation of DPCs can be achieved by comparing the amounts of radioactive DNA eluting from the filter before and after proteinase K digestion.
Zhitkovich and Costa have developed a new SDS/K + precipitation method to isolate cellular DPCs [37] . After treatment with cross-linking agents, cells are lysed in the presence of SDS and heated to 65°C, allowing for protein denaturation and dissociation of unbound proteins from DNA. SDS uniformly binds to the proteins and peptides, yielding a net negative charge on the complex [38] . The lysate is then treated with potassium chloride, and the solution is passed through a pipette tip to uniformly shear DNA. Potassium cation attachment to protein-bound SDS molecules creates a net-neutral complex that precipitates DPCs out of solution, allowing for their isolation. The presence of DNA bound to precipitated proteins can be easily detected if cellular DNA is radiolabelled by growing cells in the presence of [ 3 H]-thymidine. Alternatively, protein-associated DNA can be detected using the DNA stain Hoechst 33258. Zhitkovich and Costa successfully used this assay to detect DPCs induced by chromium, cisplatin and formaldehyde in mammalian cells [37] . However, this methodology does not separate free proteins from DPCs, as both will form SDS/K + complexes during the work-up (Table 1 ) and thus cannot be used for mass spectrometrybased proteomics to determine protein identities.
To ensure that only proteins originating from covalent DPCs are detected, unbound proteins and peptides must be separated from covalent DPCs. One of the most common techniques for DNA isolation from cells and tissues is phenolchloroform or phenol-isoamyl alcohol extraction [39] . We have adopted this methodology to isolate DPC-containing DNA from cells [12] . When nuclear lysates from treated cells are mixed with an equal volume of phenol-chloroform, three distinct layers form upon centrifugation (Scheme 2). The bottom organic solvent layer contains free proteins, while the top aqueous layer contains chromosomal DNA. The middle layer/ interface contains covalent DPCs. This partitioning allows for proteins covalently attached to DNA to be separated from the unbound nuclear proteins. After repeated extraction of the top two layers with organic solvent to remove proteins, DPC-containing DNA can be precipitated out of solution with cold ethanol for further analyses via gel electrophoresis or MSbased proteomics (Table 1) .
Barker et al. developed the DNAzol-strip and DNAzol-silica extraction methods for DPC isolation from cells. In both methods, the isolated nuclei are lysed using commercially available DNAzol, a guanidine-detergent solution optimized for DNA precipitation. Strong chaotropic agents are used to strip unbound proteins from DNA (Scheme 2) [40] . DNA containing covalent DPCs is then precipitated with cold ethanol. Although the DNAzol-strip method successfully removes noncovalently bound proteins from DPCs, there is the potential to contaminate DPCs with free DNA (Table 1 ). The DNAzolstrip methodology was applied by Barker et al. to isolate IRinduced DPCs in both CHO and human fibroblast cells [41] and by the Wang group to isolate global FA-induced DPCs from HeLa cells [42] .
In preparation for the DNAzol-silica extraction method, silica fines are activated by heating in nitric acid, and the nuclear lysates are incubated at 37°C with 4 M NaCl and 4 M urea to dissociate any unbound proteins. During the DNAzol-silica method, the lysates are then loaded onto the activated silica fines, where DNA (but not free proteins) will be adsorbed. The DNA/DPCs trapped on the silica can be subsequently eluted using 8 M NaOH. As with the DNAzolstrip methodology, there is a potential to degrade proteins on the activated silica during processing ( Table 1 ). The DNAzol-silica method was successfully used by Prasad et al. to isolate DPCs formed between PARP-1 protein and abasic sites within DNA [43] . DPC formation in vitro can be detected using denaturing gel electrophoresis [43] [44] [45] . In this approach, radiolabelled DNA duplexes are incubated with a protein of interest in the presence of a cross-linking agent. The reaction mixture is resolved by denaturing gel electrophoresis and visualized by autoradiography. Under these conditions, non-covalently bound proteins will dissociate from DNA, while covalent DPCs will remain intact and can be visualized as reduced mobility bands on the gel. This approach was utilized by Brabec et al., who demonstrated that cisplatin and related platinum compounds form covalent cross-links between DNA and high-mobility group (HMG) proteins, histone proteins, transcription factors, and replicative enzymes [46] . DPC formation in cells can also be detected by single-cell gel electrophoresis (SCGE), better known as the comet assay [47] [48] [49] [50] [51] [52] [53] . After exposure to the cross-linking agent, cells are subjected to c-irradiation to induce strand breaks. Cells are suspended on agarose-covered slides, lysed under alkaline conditions, and subjected to electrophoresis. DNA is visualized on a glass slide by staining with a fluorescent dye. The DNA fragments induced by c-irradiation will travel through the agarose gel faster than unmodified chromosomal DNA, forming a 'tail'. The presence of DPCs will decrease the length of the comet's tail, which can be recovered by pre-treatment with proteinase Scheme 2. Schematic representation of methodologies for extracting DNA-protein cross-links form cells via phenol/chloroform extraction (1), SDS/K + precipitation (2), DNAzol-strip (3) and DNAzol-silica (4).
K. The length of the comet's tail can therefore be used to estimate the amount of DPC formation. Using the comet assay, Merk and Speit were able to show a dose-dependent increase in DPC formation in V79 Chinese hamster cells treated with 0-500 lM formaldehyde (FA) [47] . Across the same range of FA concentrations, they observed an increase in sister-chromatid exchanges and micronuclei, but not in hprt mutation frequency. These results have confirmed a relationship between DPC formation and cytotoxicity/clastogenicity but not gene mutations [47] . Surprisingly, no significant differences in DPC numbers were observed in cells proficient or deficient in nucleotide excision repair or Fanconi Anaemia pathways-(XP12ROSV and GM06914) after treatment with formaldehyde [50] .
Identification of Protein Components of DPCs by Mass Spectrometry-based Proteomics
Recent developments in mass spectrometry have enabled system-wide analyses of complex protein mixtures with excellent sensitivity and specificity. In a bottom-up proteomics approach, proteins are digested with specific proteases and identified based on the molecular weights and MS/MS fragmentation patterns of the resulting peptides, which are compared to theoretical spectra present in spectral databases [54] .
To improve digestion efficiency, disulphide linkages of proteins are reduced with dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP), and the resulting thiols are alkylated with iodoacetamide to prevent their re-oxidation. Proteolytic digestion of proteins generates predictable peptide fragments due to protease-specific peptide bond cleavages.
The most common protease used in proteomics is trypsin, which cleaves proteins at the C-terminus of arginine and lysine residues [55] . Other commonly used proteases include chymotrypsin (cleaves at C-terminus of the aromatic residues tyrosine, tryptophan and phenylalanine), Lys-C (cleaves at Cterminus of lysine), Glu-C (cleaves at the C-terminus of aspartic or glutamic acid) and Arg-C (cleaves at the C-terminus of arginine and lysine) [54] . Typical bottom-up proteomics analyses utilize nano-HPLC coupled to nanospray ionization tandem mass spectrometry, preferably using high-resolution mass analysers such as Q-TOF or Orbitrap MS [54] . Data is acquired in an automated data-dependent MS/MS mode, where full scan events are followed by MS 2 or MS 3 analyses of the most abundant ions in the spectra. Details regarding mass spectrometers, liquid chromatography separation of peptides and fragmentation patterns of peptides are beyond the scope of this MiniReview and have been reviewed elsewhere [54, 56] .
Preparation of the Protein Components of DPCs for Mass Spectrometry-based Proteomics
Mass spectrometry-based proteomics provides an opportunity to conduct global, unbiased analysis of all protein components of DPCs. This approach has been successfully used to investigate DPC formation by many cross-linking agents including ionizing radiation [41, 57, 58] , reactive oxygen species, cisplatin [59] , nitrogen mustards [60] , diepoxybutane [61] and formaldehyde [42] . The overall workflow for mass spectrometry-based analysis of DPCs induced by bis-alkylating agents such as 1,2,3,4-diepoxybutane, nitrogen mustards and alkylnitrosoureas is summarized in Scheme 3. In order to utilize bottom-up proteomics to identify DPCs, the protein constituent of a DPC must be released from the DNA backbone. Because bis-electrophiles alkylate DNA at the N7 position of guanine, this creates hydrolytically labile DNA lesions susceptible to depurination. Upon heating to 90°C, such DPCs can be quantitatively released from the DNA backbone in the form of protein-guanine conjugates (Scheme 3). We have recently shown that this methodology can be modified to allow for analyses of hydrolytically stable DPCs such as those induced by reactive oxygen species by incorporating a DNA digestion step (Groehler and Tretyakova, unpublished) . After DPC extraction, DNA can be digested by nuclease enzymes to generate protein-nucleotide conjugates suitable for proteomics analyses. After their release from DNA, proteins participating in crosslinking are typically resolved by SDS-PAGE and visualized by staining with mass spectrometry-compatible stains such as Coomassie brilliant blue or silver stain [62] (fig. 1 ). Individual protein bands or gel regions corresponding to specific molecular weight ranges are excised from the gel, allowing for initial fractionation of the protein mixtures. The excised gel pieces are subjected to tryptic digestion to peptides, which are extracted from the gel matrix (Scheme 3). As an alternative to gel-based analyses, filter-aided sample preparation (FASP) techniques can be used to simplify sample preparation for MS-based proteomics [63] . In this protocol, protein capture and digestion are conducted on Microcon 30 kDa centrifugal filters (EMD Millipore, Darmstadt, Germany). This method allows for high concentrations of detergents (i.e. 8 M urea) to be used to ensure universal solubilization of proteins and to achieve better recovery. After reduction and alkylation steps, detergents can be removed by extensive washing, while the proteins remain trapped on the filter. Finally, proteins are digested to peptides using trypsin, and the resulting peptides are eluted and collected for MS analysis. For complex samples, peptides generated by FASP can be prefractionated using offline HPLC, and each fraction is separately analysed by HPLC-ESI-MS/MS, ideally using a high-resolution mass analyser such as TOF, Orbitrap or FTMS.
To allow for protein identification, experimentally observed peptide mass and MS/MS fragmentation data are entered into a software package such as Proteome Discoverer (Thermo Fisher, Waltham, MA, USA), where the fragmentation patterns are compared to spectra present in the database ( fig. 2) . Identified proteins are matched to their corresponding gene ID, creating a gene list. From here, various data mining tools can be used to probe the functions of the identified proteins. Singular enrichment analysis tools such as DAVID (Database for Annotation, Visualization and Integrated Discovery) can be used to identify the molecular and biological functions of the identified protein [64] . While large gene lists can provide an overwhelming amount of information due to the linearity of the output terms, these terms can then be condensed into relevant categories allowing enriched biological and functional themes to be detected (Scheme 4). For example, terms such as apoptosis, programmed cell death and regulation of apoptosis may be condensed under a single term, apoptosis, to simplify data output [65] . Another method of data mining that can be employed is the use of pathway analysis software, such as ingenuity pathway analysis (IPA, Qiagen). Here, the gene list is inputted into the software where relationships and canonical pathways involved can be elucidated through comparisons with an extensive collection of published experimental data [66] . These are just two examples of the numerous data mining techniques that can be utilized to extract biological meaning from the extensive gene lists produced by proteomics experiments.
Protein identities obtained from LC-MS/MS can be confirmed using immunological detection with specific antibodies, also referred to as immunoblotting. Incubation with a conjugated secondary antibody allows for visualization of these specific proteins using colorimetric or chemiluminescence detection. In preparation for immunoblotting, DPCs are digested to protein-guanine or protein-nucleoside conjugates, which can then be resolved by one-dimensional or two-dimensional gel electrophoresis. In two-dimensional gel electrophoresis, proteins are resolved by two differing properties. For instance, proteins can be initially separated by isoelectric point using a pH gradient gel and then transferred to a PAGE gel to further separate the proteins based on mass. After either gel electrophoresis technique, the gels can be incubated in the presence of specific antibodies for identification of individual proteins. Although immunological techniques are selective and sensitive, they can only detect several proteins at a time, requiring prior knowledge of protein identities.
Relative Quantitation of DPC by Quantitative Proteomics
Although traditional bottom-up mass spectrometry-based proteomics methodologies can help identify protein constituents of DPCs, they are unable to quantify DPC amounts after exposure to cross-linking agents. Background levels of DPCs are present in all living cells due to endogenous exposure to reactive oxygen species and products of lipid peroxidation, and due to inadvertent trapping of DNA topoisomerases, polymerases and repair proteins on their DNA substrates [67] [68] [69] [70] . To distinguish between endogenous and exposure-mediated cross-linking, the amounts of DPCs in control and treated cells must be compared. Quantitative proteomics techniques use stable isotope labelling of proteins or peptides to allow for relative quantitation of proteins across multiple samples/experiments [71, 72] . These quantitative proteomics protocols have been recently applied to studies of DNA-protein cross-linking, allowing for better understanding of the extent of exogenous and endogenous DPC formation, as well as to monitor their persistence and repair in cells.
One of the most powerful quantitative proteomics techniques is stable isotope labelling with amino acids in cell culture (SILAC). In this approach, isotopically labelled arginine and lysine are added to a cell culture media depleted of the corresponding native amino acids, leading to their incorporation into cellular proteins during translation [71, 73] . Adding two labelled amino acids ensures that every peptide from a proteolytically digested protein will contain at least one isotopic label [73] . In a typical SILAC experiment, experimental manipulation such as exposure to a cross-linking agent is performed with the isotopically labelled 'heavy' cells, while the control condition is performed with the normal 'light' cells. After treatment, proteins from 'light' and 'heavy' cells are combined and subjected to the traditional mass spectrometrybased proteomics workflow. As the physiochemical properties To our knowledge, SILAC has not yet been used to quantify covalent DPC formation after exposure to environmental or therapeutic bis-electrophiles. However, DNA-protein crosslinking by formaldehyde in combination with SILAC has been used to measure changes in DNA-protein binding. For example, Byrum et al. combined chromatin affinity purification with SILAC mass spectrometry to quantify changes in protein binding and histone post-translational modifications to the GAL1 loci under 'transcriptionally silent' or 'active' states in S. Cerevisiae [74] . These authors introduced a LexA binding site upstream of the GAL1 promoter in a strain of S. Cerevisiae constitutively expressing a LexA fusion protein [74] . The mutant strain of yeast was grown in regular light media, while the wild-type strain was grown in heavy media. Both strains were then exposed to glucose (to repress transcription) or galactose (to activate transcription), followed by FA treatment to cross-link bound proteins to DNA. DNA shearing and ChIP purification using a LexA antibody allowed for purification of the GAL1 loci, along with any trapped proteins. SILAC-based proteomics has enabled these authors to identify and quantify the proteins interacting with 'silent' or 'active' chromatin, as well as to eliminate any non-specific binders which manifested themselves by having 1:1 ratio of light and heavy peptide signals. A similar approach was adopted by Soldi and Bonaldi [75] to observe global changes in protein binding at transcriptionally active vs silent regions of chromatin. After treatment with FA to induce cross-linking of DNA-binding proteins to DNA, regions of chromatin were immunoprecipitated using antibodies against histone H3 with a trimethylated lysine 9 (transcriptionally repressed) [76] and histone H3 with a trimethylated lysine 4 (transcriptionally active) [77] , allowing for relative quantification of proteins binding to various regions of chromatin. These examples suggest that SILAC could also be used for quantitation of DPCs induced by endogenous and exogenous agents. However, SILAC requires in vitro labelling of proteins with heavy isotopes and thus is limited to cell culture experiments. Furthermore, multiplexing experiments are not practical due to the limited availability of isotopically labelled cell culture media and cost considerations.
Another powerful approach for protein quantification involves isotope labelling of proteins on the peptide level. The most popular chemical labelling agents are tandem mass tags (TMT, available from Thermo Fisher Scientific) ( fig. 3A) and isobaric tags for absolute and relative quantification (iTRAQ, sold by Sciex) (fig. 3B ). Both TMT and iTRAQ tags contain a mass reporter region, a mass normalizer section, an aminereactive N-hydroxysuccinimide group and the same amount of isotopic labels differentially distributed throughout the molecule (Scheme 5). These tags react with lysine and arginine residues and the N-terminal amines of tryptic peptides. Experimental samples and controls are treated with unique isotope tags, and the resulting labelled peptides are mixed together prior to HPLC-ESI-MS/MS analysis to allow for relative quantitation (Scheme 5). Upon MS/MS or MS 3 fragmentation of isotopically labelled peptides during tandem mass spectrometry analysis, characteristic product ions are observed in the spectra. As each mass reporter region will have a different number of isotopic labels, peptides from differentially labelled samples can be distinguished from each other, thus providing a characteristic signal for peptides originating from each sample/experimental condition. Furthermore, reporter ion intensities can be used for relative quantitation of each protein across samples. Commercially available kits contain four, six or eight unique labels, allowing for ready multiplexing. Our laboratory has utilized TMT labelling to quantify DPC formation in rat cardiomyocytes after myocardial infarction/ reperfusion as compared to healthy myocardium. Using 6-plex TMT methodology, we were able to observe increased DPC formation in cardiomyocytes isolated from ischaemia/reperfusion rats as compared to controls. TMT labelling has revealed DPC formation involving 34 heart proteins (Groehler and Tretyakova, unpublished observations).
Absolute Quantitation of DPCs in Cells and Tissues by
Isotope-Dilution Mass Spectrometry
While SILAC-and TMT-based proteomics allows for relative quantitation of specific DPCs in treated versus control cells/tissues, it does not provide absolute quantitation of these bulky lesions. To allow for absolute quantification of DNA-protein cross-linking, isotope-dilution tandem mass spectrometry assays have been developed. Following DPC extraction from cells and tissues, both DNA and protein constituents of DPCs are fully digested to their corresponding monomers to generate amino acid-nucleobase or amino acid-nucleoside conjugates. As mentioned above, protein-guanine conjugates induced by simple alkylating agents such as DEB, nitrogen mustards and dibromoethane, protein-guanine conjugates can be released from the DNA backbone by heating (Scheme 3). Thermally stable DPCs such as those induced by reactive oxygen species, acrolein and 4-hydroxynonenal must be enzymatically digested to proteinnucleoside conjugates prior to analysis. In both cases, protein constituents of DPCs are digested to amino acids using a combination of proteases such as trypsin and proteinase K. Authentic standards of each amino acid-nucleoside or amino acid-nucleobase conjugate and their isotopically labelled analogues can be synthesized to be used the development of sensitive HPLC-ESI-MS/MS assays. By spiking known amounts of isotopically labelled internal standard into each sample prior to HPLC-ESI-MS/MS analysis, absolute quantitation of DPCs in biological samples can be achieved. It should be noted that protein identity information is lost in this approach, as DPCs are broken down to single amino acids. However, this approach provides sensitive, precise, and accurate quantitation of total DPC numbers in cells and tissues. Our laboratory has employed stable isotope-dilution HPLC-ESI-MS/MS strategy to quantify DPC formation in human cells treated with DEB, mechlorethamine, phosphoramide mustard, and cisplatin using authentic standards of 1-
respectively. All bis-electrophiles investigated in these studies induced dose-dependent DPC formation in treated cells. DPC numbers in HT1080 cells treated with 50 lM mechlorethamine were 2 per 10 6 nucleotides, while structurally related phosphoramide mustard induced 0.03 lesions per 10 6 nucleotides [12, 13] .
The Swenberg laboratory utilized isotope-dilution tandem mass spectrometry to quantify endogenous and exogenous formaldehyde-induced DPC adducts in tissues of laboratory animals treated with 13 C-formaldehyde [78] . Because cross-links induced by exogenous 13 C-FA carry the 13 C label, they can be readily distinguished from endogenously generated lesions that contain natural isotopes only. Endogenous DPCs were detected in the nose, PBMC, bone marrow and liver tissues of non-human primates and in the nasal mucosa, PBMC and bone marrow of laboratory rats treated with 13C-FA [78] . However, FA-induced DPCs were only detected in the nose/nasal mucosa of FAexposed laboratory animals, suggesting that endogenous DPCs are likely to play a role in the aetiology of leukaemia [78] [79] [80] [81] .
Applications of Mass Spectrometry-based Proteomics in DPC Characterization
1,2,3,4-Diepoxybutane. 1,2,3,4-diepoxybutane (DEB) is a carcinogenic diepoxide produced upon metabolic activation of 1,3-butadiene (BD) by CYP 2E1 [82] [83] [84] . BD is an industrial chemical widely used in the polymer industry and also an environmental chemical present in automobile exhaust, cigarette smoke and forest fires [85, 86] . Based on association between BD exposure and leukaemia/lymphoma risk in occupationally exposed workers and its ability to induce tumours in laboratory animals, BD is classified as known human and animal carcinogen [87] . Among all metabolites of BD, DEB is by far the most genotoxic and carcinogenic and is considered the ultimate carcinogenic species of BD [88] [89] [90] . The biological activity of DEB is attributed to its ability to form DNA-DNA and DNAprotein cross-links. DEB alkylates the N7 position of guanine to yield 2-hydroxy-3,4-epoxybut-1-yl monoadducts [91] , which can subsequently react with the nucleophilic residues of proteins to form 1,4-butane-2,3-diol cross-links (structure 1 in Scheme 1) [61] . The first report of DEB-induced DPCs was by Jelitto et al. [91] , who utilized an alkaline elution method to observe DPCs in liver tissues of BD-exposed B6C3F1 mice. More recently, several laboratories reported DEBinduced DPC formation in vitro using O 6 -alkylguanine-DNA alkyltransferase (AGT) involved in DNA repair [61] , glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein involved in glycolysis [92] and the conjugating enzyme glutathione S-transferase (GST) [93] .
Our laboratory was the first to utilize mass spectrometrybased proteomics to identify the protein constituents of DEBinduced DPCs. In our in vitro studies, biotinylated DNA duplexes were incubated with human cervical carcinoma (HeLa) protein extracts in the presence of DEB, and the resulting DPCs were purified using streptavidin beads [94] . Mass spectrometry-based proteomics identified 39 proteins participating in cross-linking, including known DNA-binding proteins such as GAPDH, flap endonuclease-1 (FEN-1) and poly [ADP ribose] polymerase 1 (PARP) [94] . To investigate DEBinduced DPC formation in living cells, human fibrosarcoma (HT1080) cells were treated with DEB, and DPCs were extracted from nuclear lysate using the modified phenol-chloroform extraction methodology (Scheme 3). MS-based proteomics of proteins associated with DNA following DEB treatment has identified a total of 152 proteins ( fig. 4) [95] . Of these, 103 (76.3%) were known nuclear proteins or chromosomal binding proteins, while the rest were identified as cytoplasmic (18.4%) and membrane proteins (7.2%) ( fig. 4A ). Over 60% of the identified proteins had known DNA-/RNAbinding activity, including high-mobility group protein 1 (HMG-1), Bcl-2 transcription factor 1 (involved in tumour suppression), and apoptosis-antagonizing transcription protein (AATF) ( fig. 4B) [95] . Also identified were lamin B2 and tubulin (cell motility and architecture), nucleolin and nucleophosmin (cellular homeostasis), nucleolar proteins, and RRP15-like protein (RNA processing/mRNA processing), showing a great diversity in proteins that are susceptible to cross-linking to DNA in the presence of DEB [95] .
Formaldehyde. Formaldehyde (FA) is an ubiquitous environmental carcinogen present in automobile exhaust, cigarette smoke, pharmaceuticals, resins coating particle board and plywood, and vapours from these products [96] . FA is also produced endogenously as a product of metabolic processes such as methanol oxidation, methylamine deamination [97] , and histone demethylation [98, 99] . Increased levels of FA-mediated DPCs have been found in tissues from occupationally exposed physicians, laboratory technicians, and orderlies [22, 100] . Furthermore, FAinduced DPCs have been measured in the nasal mucosa of laboratory rats and non-human primates exposed to FA by inhalation [78] .
FA-mediated DNA-protein cross-linking takes place between lysine, histidine, tryptophan, and cysteine residues of proteins and dG, dA, and dC nucleosides of DNA (Scheme 1) [101] . Cross-linking initially generates Schiff base intermediates on proteins or DNA, which are converted to methylene cross-links upon reaction with another biomolecule (structure 4 in Scheme 1). FA-induced DPCs are reversible upon heating, a process exploited by the biochemical assay chromatin immunoprecipitation (ChIP). Recently, mass spectrometrybased proteomics technique has been coupled to traditional ChIP to allow untargeted identification of proteins bound to specific DNA regions [75, 102, 103] .
To identify proteins that bind to telomeric repeats within DNA, Nittis et al. [104] overexpressed epitope-labelled Tin2, a protein critical for the assembly of the shelterin complex on telomeres, in 293T cells. After cross-linking proteins to DNA with FA, the telomere region was selectively precipitated using HA-FLAG-Tin2 antibody by standard ChIP protocol [104] . All cross-linked proteins were then released from the DNA by heating and prepared for bottom-up proteomics analysis. Along with all the proteins of the shelterin complex, 62 novel telomere binding proteins, including the transcriptional regulators matrin-3 and TAR DNA-binding protein, were identified, providing evidence that telomeres are actively transcribed [104] . Similar approaches coupling FA-induced DPC formation and ChIP have been developed to identify Histone H2A binding partners [105] and loci-specific chromatin binding proteins [106] .
Nitrogen mustards.
Nitrogen mustards (NMs) are anticancer drugs used as firstline chemotherapy treatments for lymphoma, leukaemia, myeloma, breast, and brain cancers, and also in bone marrow transplantation [107] . Examples of clinically useful NMs include cyclophosphamide (CP), mechlorethamine, chlorambucil, melphalan, and ifosfamide [108, 109] . The biological effects of NMs are attributed to their ability to induce DNA-DNA and DNA-protein cross-links, which interfere with DNA replication, ultimately leading to apoptosis. All NMs contain two N-(2-chloroethyl) groups, which can form reactive aziridinium ions capable of alkylating nucleophilic positions on DNA and proteins to form DPCs. The majority of NMinduced DPCs involve the N7 position of guanine and cysteine residues of proteins [60] .
The first observation of NM-induced DPCs was made by Ewig et al. [35] , who utilized an alkaline elution approach to detect DPCs in mouse leukaemia cells (L1210) treated with nornitrogen mustard. Hansson et al. [110] utilized the same methodology to observe nornitrogen mustard and melphalaninduced DPC formation in human melanoma (RPMI 8322) cells. Our laboratory employed the affinity capture technique mentioned above to identify 15 Chinese hamster ovary and 53 HeLa nuclear proteins that formed DPCs after exposure to mechlorethamine in vitro [11, 12] .
More recently, we characterized DPC formation in human fibrosarcoma (HT1080) cells treated with phosphoramide mustard (PM) [13] . PM is considered the active metabolite of cyclophosphamide and is formed after CP is oxidized by CYP450 2B6 or 3A4 [111] [112] [113] [114] . Cells were treated with 100 lM PM, and DPCs were isolated by modified phenolchloroform extraction. Proteins covalently attached to DNA in the presence of PM were characterized by bottom-up proteomics with a LTQ Orbitrap Velos [13] . These analyses have identified 134 proteins that became cross-linked to DNA only after exposure to PM [13] . Isotope-dilution tandem mass spectrometry using 15 
Cisplatin.
Platinum compounds such as cis-diamminedichloroplatinum (II) (cisplatin), carboplatin, and oxaliplatin are another class of commonly used cancer chemotherapeutics. Cisplatin was the first FDA-approved platinum anticancer drug and is still widely used to treat bladder, head and neck, lung, ovarian, and testicular cancers [115, 116] . Although DNA-DNA intrastrand cross-linking is considered to be the major mechanism of activity of platinum agents, DPCs are likely to contribute to the observed therapeutic effects. Significant levels of DPCs have been observed after cisplatin exposure of human HT1080 cells [44] . Unlike other bis-electrophiles that are selective for cysteine side chains, cisplatin can use cysteine, arginine, and lysine side chains to form DPCs [44, 59] . Our laboratory investigated cisplatin-induced DPC formation in human HT1080 cells and identified 256 distinct crosslinked proteins (Ming et al., in press ). The significant increase in DPC numbers in cisplatin-treated cells as compared to nitrogen mustards and diepoxybutane-treated cells can be partially explained by cisplatin's ability to form DPCs at many different sites including cysteine, lysine, and arginine residues. Of the 256 proteins cross-linked to DNA in the presence of cisplatin, 75 (31.5%) are known DNA-or RNA-binding proteins. Considering that DNA-and RNA-binding proteins constitute only 10% of the total nuclear proteome, this indicates that proteins with known affinity for nucleic acids are preferentially targeted for cross-linking. Taken together, our proteomics results demonstrate the efficiency of DPC formation after exposure to platinum drugs and suggest that DPC formation contributes to the observed antitumour activity.
Conclusions and Future Directions
DNA-protein cross-links are ubiquitous DNA adducts readily formed in cells as a result of exposure to bis-electrophiles, ionizing radiation, reactive oxygen species, and transition metals. Mass spectrometry-based proteomics techniques have allowed the protein constituents of DPCs to be identified, giving initial insight into the identities of the proteins participating in cross-linking. Recent advances in quantitative proteomics techniques have yielded effective methods for relative quantification of specific DPCs in treated versus untreated cells and tissues. Furthermore, absolute quantitation of total DPC numbers can be achieved by isotope-dilution HPLC-ESI-MS/MS. Further implementation of these novel mass spectrometry methodologies and technologies will improve our understanding of the molecular structures, identities, cellular abundance, persistence, and the global biological consequences of DPC formation.
